Now showing items 1-2 of 2

    • Safety and effectiveness of BufferGel and 0.5% PRO 2000 gel for the prevention of HIV infection in women. 

      Abdool Karim, Salim Safurdeen.; Richardson, Barbra A.; Ramjee, Gita.; Hoffman, Irving F.; Chirenje, Zvavahera M.; Taha, Taha.; Kapina, Muzala.; Maslankowski, Lisa.; Coletti, Anne.; Profy, Albert.; Moench, Thomas R.; Piwowar-Manning, Estelle.; Masse, Benoıt.; Hillier, Sharon L.; Soto-Torres, Lydia. (Lippincott Williams & Wilkins., 2011-02-01)
      Objective: To determine the safety and effectiveness of BufferGel and 0.5% PRO2000 microbicide gels for the prevention of male-to-female HIV transmission. Design: Phase II/IIb, randomized, placebo-controlled trial with ...
    • Utility of colposcopy in a phase 2 portion of a microbicide clinical trial of BufferGel and 0.5% PRO 2000 Gel. 

      Chirenje, Zvavahera M.; Masse, Benoit.; Maslankowski, Lisa.; Ramjee, Gita.; Coletti, Anne.; Tembo, Tchangani.; Magure, Tsitsi M.; Soto-Torres, Lydia.; Kelly, Cliff.; Hillier, Sharon L.; Abdool Karim, Salim Safurdeen. (BioMed Central / International AIDS Society., 2012-07-27)
      Background: The majority of new HIV infections are acquired through heterosexual transmission. There is urgent need for prevention methods to compliment behavior change and condom use. Topical microbicide represent a ...